Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transdermal clonidine: therapeutic considerations.

Domenic A Sica1, Rebecca Grubbs

  • 1Section of Clinical Pharmacology and Hypertension, Division of Nephrology, Medical College of Virginia of Virginia Commonwealth University, Richmond, VA 23298, USA. dsica@hsc.vcu.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiopulmonary Baroreflex Control of Renal Sympathetic Nerve Activity Is Impaired in Dogs With Left Ventricular Dysfunction.

Journal of cardiac failure·2019
Same author

Does the benefit from treating to lower blood pressure targets vary with age? A systematic review and meta-analysis.

Journal of hypertension·2019
Same author

History and Justification of a National Blood Pressure Measurement Validated Device Listing.

Hypertension (Dallas, Tex. : 1979)·2018
Same author

Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.

Journal of clinical hypertension (Greenwich, Conn.)·2018
Same author

Subcutaneous Furosemide in Heart Failure: Pharmacokinetic Characteristics of a Newly Buffered Solution.

JACC. Basic to translational science·2018
Same author

Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: a head-to-head meta-analysis.

Journal of hypertension·2018

Transdermal clonidine effectively treats hypertension and other conditions. However, skin irritation and higher costs limit its use compared to oral clonidine.

Area of Science:

  • Pharmacology and Therapeutics
  • Dermatology

Background:

  • Transdermal clonidine, approved in 1984, offers a consistent drug release similar to infusion therapy.
  • It is a recognized treatment for mild-to-moderate hypertension, used alone or with diuretics.

Purpose of the Study:

  • To review the efficacy and limitations of transdermal clonidine.
  • To explore its established and emerging therapeutic applications.

Main Methods:

  • Review of clinical data and FDA-approved indications for transdermal clonidine.
  • Analysis of pharmacokinetic properties and comparative cost-effectiveness.

Main Results:

  • Transdermal clonidine demonstrates efficacy comparable to oral formulations for hypertension.

Related Experiment Videos

  • It has expanded applications including smoking cessation, PTSD, hot flashes, and withdrawal syndromes.
  • Common side effects include dermatitis, and it is more expensive than oral clonidine.

    • Conclusions:

    • Transdermal clonidine is a versatile therapeutic agent for hypertension and various other conditions.
    • Despite its efficacy, the incidence of dermatitis and higher cost present significant drawbacks.
    • Its use may be limited by these adverse effects and economic factors.